The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Three-dimensional saturated C(sp3)-rich bioisosteres for benzene
Open accessAbstract
Benzenes, the most ubiquitous structural moiety in marketed small-molecule drugs, are frequently associated with poor ‘drug-like’ properties, including metabolic instability, and poor aqueous solubility. In an effort to overcome these limitations, recent developments in medicinal chemistry have demonstrated the improved physicochemical profiles of C(sp3)-rich bioisosteric scaffolds relative to arenes. In the past two decades, we have witnessed an exponential increase in synthetic methods for accessing saturated bioisosteres of monosubstituted and para-substituted benzenes. However, until recent discoveries, analogous three-dimensional ortho-substituted and meta-substituted biososteres have remained underexplored, owing to their ring strain and increased s-character hybridization. This Review summarizes the emerging synthetic methodologies to access such saturated motifs and their impact on the application of bioisosteres for ortho-substituted, meta-substituted and multi-substituted benzene rings. It concludes with a perspective on the development of next-generation bioisosteres, including those within novel chemical space. In this Review, synthetic approaches to polycyclic scaffolds, which can act as saturated, three-dimensional bioisosteric replacements of ortho-substituted, meta-substituted and multi-substituted benzenes, are discussed. Their application in medicinal chemistry is also summarized. To overcome poor developability and provide better ‘drug-like’ properties of phenyl rings, various modular synthetic approaches to access bicycloalkanes and other polycyclic scaffolds have been achieved, with these scaffolds considered modern saturated (bio)isosteric replacements. (Bio)isosteric replacements of para-arenes with collinear geometry, such as 1,3-bicyclo[1.1.1]pentanes, 1,4-bicyclo[2.2.2]octanes and 1,4-cubanes, have been proposed, generated and applied in drug development, motivating synthetic chemists to develop novel methodologies to access such scaffolds. Because ortho-substituted, meta-substituted and multi-substituted arenes occupy a large ratio of benzoid substitution patterns, bicycloalkanes with a variety of substitutions have been synthesized and demonstrated to act as (bio)isosteric replacements of such arenes, exemplified by multi-substituted bicyclo[1.1.1]pentanes, bicyclo[2.1.1]hexanes, bicyclo[3.1.1]heptanes and bicyclo[2.2.2]octanes. Besides bicyclic scaffolds, other polycyclic frameworks including cubanes, cuneanes, stellanes, ladderanes and spiro[3.3]heptanes have also been hypothesized and synthesized and their potential (bio)isosteric roles showcased. Beyond hydrocarbons, heteroatom‐embedded saturated motifs may result in candidates with better drug-like properties leading to oxa-bicyclic and aza-bicyclic scaffolds gaining increasing focus from synthetic and medicinal chemistry community. The different geometry between aromatics and their bioisosteric replacement might cause unexpected outcomes on their biological activities and physicochemical and pharmacokinetic properties, which will motivate the whole community to continue looking for next generation of bioisosteres and exploring novel chemical space. To overcome poor developability and provide better ‘drug-like’ properties of phenyl rings, various modular synthetic approaches to access bicycloalkanes and other polycyclic scaffolds have been achieved, with these scaffolds considered modern saturated (bio)isosteric replacements. (Bio)isosteric replacements of para-arenes with collinear geometry, such as 1,3-bicyclo[1.1.1]pentanes, 1,4-bicyclo[2.2.2]octanes and 1,4-cubanes, have been proposed, generated and applied in drug development, motivating synthetic chemists to develop novel methodologies to access such scaffolds. Because ortho-substituted, meta-substituted and multi-substituted arenes occupy a large ratio of benzoid substitution patterns, bicycloalkanes with a variety of substitutions have been synthesized and demonstrated to act as (bio)isosteric replacements of such arenes, exemplified by multi-substituted bicyclo[1.1.1]pentanes, bicyclo[2.1.1]hexanes, bicyclo[3.1.1]heptanes and bicyclo[2.2.2]octanes. Besides bicyclic scaffolds, other polycyclic frameworks including cubanes, cuneanes, stellanes, ladderanes and spiro[3.3]heptanes have also been hypothesized and synthesized and their potential (bio)isosteric roles showcased. Beyond hydrocarbons, heteroatom‐embedded saturated motifs may result in candidates with better drug-like properties leading to oxa-bicyclic and aza-bicyclic scaffolds gaining increasing focus from synthetic and medicinal chemistry community. The different geometry between aromatics and their bioisosteric replacement might cause unexpected outcomes on their biological activities and physicochemical and pharmacokinetic properties, which will motivate the whole community to continue looking for next generation of bioisosteres and exploring novel chemical space.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Lovering, F., Bikker, J., & Humblet, C. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901241e · Cited by 4,495
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
Meanwell, N. A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1013693 · Cited by 2,854
Rings in Drugs: Miniperspective
Taylor, R. D., MacCoss, M., & Lawson, A. D. G. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4017625 · Cited by 2,543
Aromatic Rings in Chemical and Biological Recognition: Energetics and Structures
Salonen, L. M., Ellermann, M., & Diederich, F. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201007560 · Cited by 1,539
Escape from Flatland 2: complexity and promiscuity
Lovering, F. (2013) · MedChemComm · doi:10.1039/c2md20347b · Cited by 1,444
Aromatic substituent constants for structure-activity correlations
Hansch, C., Leo, A., Unger, S. H., Kim, K. H., Nikaitani, D., & Lien, E. J. (1973) · Journal of Medicinal Chemistry · doi:10.1021/jm00269a003 · Cited by 1,262
Ritchie, T. J., & Macdonald, S. J. F. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.07.014 · Cited by 901
The Concept of Strain in Organic Chemistry
Wiberg, K. B. (1986) · Angewandte Chemie International Edition in English · doi:10.1002/anie.198603121 · Cited by 745
Bioisosteres of the Phenyl Ring: Recent Strategic Applications in Lead Optimization and Drug Design
Subbaiah, M. A. M., & Meanwell, N. A. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01215 · Cited by 710
Saturated bioisosteres of benzene: where to go next?
Mykhailiuk, P. K. (2019) · Organic & Biomolecular Chemistry · doi:10.1039/c8ob02812e · Cited by 613
Formation and Biological Targets of Quinones: Cytotoxic versus Cytoprotective Effects
Bolton, J. L., & Dunlap, T. (2017) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00256 · Cited by 522
Stepan, A. F., Subramanyam, C., Efremov, I. V., Dutra, J. K., O’Sullivan, T. J., DiRico, K. J., McDonald, W. S., Won, A., Dorff, P. H., Nolan, C. E., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300094u · Cited by 468
Utilization of operational schemes for analog synthesis in drug design
Topliss, J. G. (1972) · Journal of Medicinal Chemistry · doi:10.1021/jm00280a002 · Cited by 457
Intermolecular [2π+2σ]-photocycloaddition enabled by triplet energy transfer
Kleinmans, R., Pinkert, T., Dutta, S., Paulisch, T. O., Keum, H., Daniliuc, C. G., & Glorius, F. (2022) · Nature · doi:10.1038/s41586-022-04636-x · Cited by 455
Ritchie, T. J., Macdonald, S. J. F., Young, R. J., & Pickett, S. D. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2010.11.014 · Cited by 442
Eaton, P. E., & Cole, T. W. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01059a072 · Cited by 421
The 25th Anniversary of the Buchwald–Hartwig Amination: Development, Applications, and Outlook
Forero-Cortés, P. A., & Haydl, A. M. (2019) · Organic Process Research & Development · doi:10.1021/acs.oprd.9b00161 · Cited by 360
Acetaminophen Hepatotoxicity and Acute Liver Failure
Chun, L. J., Tong, M. J., Busuttil, R. W., & Hiatt, J. R. (2009) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31818a3854 · Cited by 348
Young, R. J., Green, D. V. S., Luscombe, C. N., & Hill, A. P. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.06.001 · Cited by 311
Impact of Cross-Coupling Reactions in Drug Discovery and Development
Buskes, M. J., & Blanco, M.-J. (2020) · Molecules · doi:10.3390/molecules25153493 · Cited by 296
Bellotti, P., & Glorius, F. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c08206 · Cited by 294
Photochemical intermolecular dearomative cycloaddition of bicyclic azaarenes with alkenes
Ma, J., Chen, S., Bellotti, P., Guo, R., Schäfer, F., Heusler, A., Zhang, X., Daniliuc, C., Brown, M. K., Houk, K. N., et al. (2021) · Science · doi:10.1126/science.abg0720 · Cited by 263
Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity
Hill, A. P., & Young, R. J. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.05.016 · Cited by 258
Investigation of a Bicyclo[1.1.1]pentane as a Phenyl Replacement within an LpPLA 2 Inhibitor
Measom, N. D., Down, K. D., Hirst, D. J., Jamieson, C., Manas, E. S., Patel, V. K., & Somers, D. O. (2017) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00281 · Cited by 253
Zheng, Y., Huang, W., Dhungana, R. K., Granados, A., Keess, S., Makvandi, M., & Molander, G. A. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c11501 · Cited by 236
Propellanes—From a Chemical Curiosity to “Explosive” Materials and Natural Products
Dilmaç, A. M., Spuling, E., de Meijere, A., & Bräse, S. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201603951 · Cited by 235
Dearomative ring expansion of thiophenes by bicyclobutane insertion
Wang, H., Shao, H., Das, A., Dutta, S., Chan, H. T., Daniliuc, C., Houk, K. N., & Glorius, F. (2023) · Science · doi:10.1126/science.adh9737 · Cited by 224
Rayadurgam, J., Sana, S., Sasikumar, M., & Gu, Q. (2021) · Organic Chemistry Frontiers · doi:10.1039/d0qo01146k · Cited by 214
Aguilar, A., Lu, J., Liu, L., Du, D., Bernard, D., McEachern, D., Przybranowski, S., Li, X., Luo, R., Wen, B., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01665 · Cited by 211
Pellicciari, R., Raimondo, M., Marinozzi, M., Natalini, B., Costantino, G., & Thomsen, C. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960254o · Cited by 202
Nguyen, T. V. T., Bossonnet, A., Wodrich, M. D., & Waser, J. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c09789 · Cited by 190
Validating Eaton's Hypothesis: Cubane as a Benzene Bioisostere
Chalmers, B. A., Xing, H., Houston, S., Clark, C., Ghassabian, S., Kuo, A., Cao, B., Reitsma, A., Murray, C. P., Stok, J. E., et al. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201510675 · Cited by 186
A General Route to Bicyclo[1.1.1]pentanes through Photoredox Catalysis
Nugent, J., Arroniz, C., Shire, B. R., Sterling, A. J., Pickford, H. D., Wong, M. L. J., Mansfield, S. J., Caputo, D. F. J., Owen, B., Mousseau, J. J., et al. (2019) · ACS Catalysis · doi:10.1021/acscatal.9b03190 · Cited by 182
Designing around Structural Alerts in Drug Discovery
Kalgutkar, A. S. S. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00917 · Cited by 173
Tse, E. G., Houston, S. D., Williams, C. M., Savage, G. P., Rendina, L. M., Hallyburton, I., Anderson, M., Sharma, R., Walker, G. S., Obach, R. S., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00746 · Cited by 166
Cubanes in Medicinal Chemistry
Reekie, T. A., Williams, C. M., Rendina, L. M., & Kassiou, M. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00888 · Cited by 160
Analysis of Benzenoid Substitution Patterns in Small Molecule Active Pharmaceutical Ingredients
Nilova, A., Campeau, L., Sherer, E. C., & Stuart, D. R. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00915 · Cited by 147
Zhao, J., Chang, Y., He, C., Burke, B. J., Collins, M. R., Bel, M. D., Elleraas, J., Gallego, G. M., Montgomery, T. P., Mousseau, J. J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2108881118 · Cited by 131
Goh, Y. L., Cui, Y. T., Pendharkar, V. V., & Adsool, V. A. (2017) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00018 · Cited by 124
Photochemical Formal (4 + 2)-Cycloaddition of Imine-Substituted Bicyclo[1.1.1]pentanes and Alkenes
Harmata, A. S., Spiller, T. E., Sowden, M. J., & Stephenson, C. R. J. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c10541 · Cited by 115
Homolytic C−H and N−H Bond Dissociation Energies of Strained Organic Compounds
Feng, Y., Liu, L., Wang, J.-T., Zhao, S., & Guo, Q. (2004) · The Journal of Organic Chemistry · doi:10.1021/jo035306d · Cited by 108
O-, N- and C-bicyclopentylation using thianthrenium reagents
Alvarez, E. M., Bai, Z., Pandit, S., Frank, N., Torkowski, L., & Ritter, T. (2023) · Nature Synthesis · doi:10.1038/s44160-023-00277-8 · Cited by 102
Profiling and Application of Photoredox C(sp3)–C(sp2) Cross-Coupling in Medicinal Chemistry
Zhang, R., Li, G., Wismer, M. K., Váchal, P., Colletti, S. L., & Shi, Z. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00183 · Cited by 97
Lamanna, C., Bellini, M., Padova, A., Westerberg, G., & Maccari, L. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701407x · Cited by 86
Houston, S. D., Fahrenhorst‐Jones, T., Xing, H., Chalmers, B. A., Sykes, M. L., Stok, J. E., Soto, C. F., Burns, J. M., Bernhardt, P. V., Voss, J. J. D., et al. (2019) · Organic & Biomolecular Chemistry · doi:10.1039/c9ob01238a · Cited by 78
Investigating Bicyclobutane–Triazolinedione Cycloadditions as a Tool for Peptide Modification
Schwartz, B. D., Smyth, A. P., Nashar, P. E., Gardiner, M. G., & Malins, L. R. (2022) · Organic Letters · doi:10.1021/acs.orglett.1c04071 · Cited by 77
Rationalizing the diverse reactivity of [1.1.1]propellane through σ–π-delocalization
Sterling, A. J., Dürr, A. B., Smith, R. C., Anderson, E. A., & Duarte, F. (2020) · Chemical Science · doi:10.1039/d0sc01386b · Cited by 75
2-Oxabicyclo[2.2.2]octane as a new bioisostere of the phenyl ring
Levterov, V. V., Panasiuk, Y. V., Sahun, K., Stashkevych, O., Badlo, V., Shablykin, O. V., Sadkova, I. V., Bortnichuk, L., Klymenko‐Ulianov, O., Holota, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41298-3 · Cited by 72
Brown, D. G., Gagnon, M. M., & Boström, J. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501894t · Cited by 70
Takale, B. S., Kong, F., & Thakore, R. R. (2022) · Organics · doi:10.3390/org3010001 · Cited by 66
Peptidyl-Prolyl Model Study: How Does the Electronic Effect Influence the Amide Bond Conformation?
Mykhailiuk, P. K., Kubyshkin, V., Bach, T., & Budiša, N. (2017) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.7b00803 · Cited by 63
Visible‐Light Promoted Intramolecular para ‐Cycloadditions on Simple Aromatics
Chiminelli, M., Serafino, A., Ruggeri, D., Marchiò, L., Bigi, F., Maggi, R., Malacrìa, M., & Maestri, G. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202216817 · Cited by 56
Potent and Orally Bioavailable 8-Bicyclo[2.2.2]octylxanthines as Adenosine A1 Receptor Antagonists
Kiesman, W. F., Zhao, J. X., Conlon, P. R., Dowling, J. E., Petter, R. C., Lutterodt, F., Jin, X., Smits, G. J., Fure, M., Jayaraj, A. A., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0605381 · Cited by 43
Spiro[3.3]heptane as a Saturated Benzene Bioisostere**
Prysiazhniuk, K., Datsenko, O. P., Поліщук, О., Shulha, S., Shablykin, O. V., Nikandrova, Y., Horbatok, K., Bodenchuk, I., Borysko, P., Shepilov, D., et al. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202316557 · Cited by 41
Cyclooctatetraene: A Bioactive Cubane Paradigm Complement
Xing, H., Houston, S. D., Chen, X., Ghassabian, S., Fahrenhorst‐Jones, T., Kuo, A., Murray, C. P., Conn, K., Jaeschke, K. N., Jin, D., et al. (2019) · Chemistry - A European Journal · doi:10.1002/chem.201806277 · Cited by 38
Enabling Deoxygenative C(sp2)-C(sp3) Cross-Coupling for Parallel Medicinal Chemistry
Liu, W., Mulhearn, J. J., Hao, B. N., Cañellas, S., Last, S., Gómez, J. E., Jones, A. X., Vera, A. D., Kumar., K., V, Rodríguez, R., et al. (2023) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.3c00118 · Cited by 34
Photosensitized Cyclization of Myrcene: The Problem of Addition of Dienes to Alkenes
Liu, R. S. H., & Hammond, G. S. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01063a076 · Cited by 31
Advances in Nonclassical Phenyl Bioisosteres for Drug Structural Optimization
Li, H., Gao, Y., & Ma, J. (2022) · Future Medicinal Chemistry · doi:10.4155/fmc-2022-0188 · Cited by 29
Discovery of DS-1971a, a Potent, Selective NaV1.7 Inhibitor
Shinozuka, T., Kobayashi, H., Suzuki, S. T., Tanaka, K., Karanjule, N. S., Hayashi, N., Tsuda, T., Tokumaru, E., Inoue, M., Ueda, K., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00259 · Cited by 26
A Metal-Free Cyclobutadiene Reagent for Intermolecular [4 + 2] Cycloadditions
Boswell, B. R., Mansson, C. M. F., Cabrera, G. E., et al. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c01591 · Cited by 16
Tolcher, A. W., Fang, D. D., Li, Y., Tang, Y., Ji, J., Wang, H., Karim, R., Rosas, C., Huang, Y., & Zhai, Y. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz027 · Cited by 13
Elliott, L. D., Booker‐Milburn, K. I., & Lennox, A. J. J. (2021) · Organic Process Research & Development · doi:10.1021/acs.oprd.1c00187 · Cited by 13
Metadata
- Authors
- Tsien, J., Hu, C., Merchant, R. R., & Qin, T.
- Venue
- Nature Reviews Chemistry
- Published
- 2024-07-09
- Volume
- 8
- Issue
- 8
- Pages
- 605-627
- ISSN
- 2397-3358 (ISSN-L)
- OpenAlex
- W4400460989
- Cited by
- 263
- References
- 64
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.